- Home
- Companies
- australasia
- in vitro study
Refine by
In Vitro Study Suppliers Serving Australasia
46 companies found
based inParis, FRANCE
Laboratoires Fillmed : A French major playor with an objective of 360° approach to skin rejuvenation. Founded in 1978, FILLMED has been developing high performance products to prevent and correct signs of skin ageing: ART FILLER dermal fillers, NCTF ...
based inMelbourne, AUSTRALIA
Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and ...
based inSunnyvale, CALIFORNIA (USA)
JSR Life Sciences brings together the deep biochemical knowledge and understanding of human disease, expertise in drug discovery and development, and access to capital into a single, integrated framework that creates value for our customers. JSR ...
based inTainan City, TAIWAN
Leadgene Biomedical Inc. is founded in 2013 and headquarters in Tainan, Taiwan. In the past years, we have become an all-around solution provider for proteomics study with more than thirty staff members from a three-scientists workshop, ...
based inRio Grande, NEW JERSEY (USA)
We deliver wound therapies for superior outcomes. AediCell provides safe, effective, and easy to use products at a lower overall cost. Aedicell® is a regenerative medicine company that has developed a unique proprietary process to transform human ...
The only product on the market that combines human tissue sourced from the amniotic/chorionic membrane, umbilical cord AND placental disc —Dermavest®. This combination delivers a myriad of cell attachment proteins (CAP) including collagen, ...
based inNorth Ryde, AUSTRALIA
Biotron Limited (Biotron) is a clinical stage publicly listed Australian Biotechnology Company based in Sydney, Australia. The company is developing and commercialising a novel small molecule approach that has the potential to treat a number of ...
Biotron is developing novel small molecule antiviral therapeutics targeting a range of viruses including Hepatitis C virus (HCV) and ...
based inPhiladelphia, PENNSYLVANIA (USA)
Allevi creates tools and solutions to design, engineer and build with life. Our 3D bioprinters and bioinks are used around the world to find solutions to humanity’s most difficult problems – to cure disease, to test novel drugs, and to eliminate the ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. Headquartered in Vancouver, Canada, the company started manufacturing analytical instrumentation based on a ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Mifepristone (RU486) is a progesterone receptor (PR) and glucocorticoid receptor (GR) antagonist with IC50s of 0.2 nM and 2.6 nM in in vitro ...
based inMontreal, QUEBEC (CANADA)
SCIREQ strives to make a strong impact on global pulmonary health by empowering scientists to better understand and eradicate lung diseases. The global burden of respiratory diseases is primarily driven by asthma, chronic obstructive pulmonary ...
based inTrabzon, TURKEY
Dogsan, the first suture manufacturer of Turkey, Middle East and Balkan states, is founded in 1970 and have a long history in suture manufacturing. Competing with the global brands, Dogsan have gained its power from 45 year of expertise, almost 50 ...
PEGELAK sutures are synthetic absorbable sterile surgical sutures which are flexible strands composed of a copolymer prepared and synthesized from 90 percent glycolide and 10 percent L-lactide (derived from glycolic and lactic acids) and are ...
based inPipersville, PENNSYLVANIA (USA)
LAMPIRE specializes in custom polyclonal & monoclonal antibody development, secondary antibodies, IgGs, BSA, animal blood, tissues & organs, normal & disease state human serums & plasmas, cell media, OMNI C3 cell culture bags & contract ...
based inAlachua, FLORIDA (USA)
RTI Surgical (RTI) is a global, industry leading surgical implant supplier that provides design, new product development, processing and manufacturing services in support of patients and leading medical technology companies. With expertise in tissue ...
RTI Surgical offers the only meniscal allograft with both bone and meniscus sterilized through the BioCleanse® Tissue Sterilization Process. The BioCleanse processed meniscus graft provides a sterilized alternative to traditional aseptically ...
based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...
based inBudapest, HUNGARY
CycloLab is a worldwide recognized and all-around cyclodextrin research and development company, having the longest tradition and broadest circle of customers. Since 1972, a staff of internationally acknowledged experts have been working in the ...
Incorporating new APIs into final products might prove challenging: stability, solubility, bioavailability, etc. issues may arise. Several attributes of these substances can be favorably altered by cyclodextrins. Cyclodextrins themselves can also ...
based inAlbano Laziale (RM), ITALY
Founded in 1980, with global headquarters in Rome (Italy), COSMED is a privately owned company manufacturing Cardio Pulmonary, Metabolic and Body Composition diagnostic equipment. Since its foundation, COSMED's primary goal has always been to ...
Q-NRG is the first Indirect Calorimeter specifically intended for Resting Energy Expenditure (REE) measurement on spontaneously breathing subjects. Indirect calorimetry provides an individual and dynamic metabolic assessment based on the actual ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
TP-0184 is an investigational inhibitor of activin receptor-like kinase 2 (ALK2) and ALK5 (also known as TGFβR1). This bimodal inhibitor is believed to downregulate multiple TGF-β superfamily signaling pathways and has shown antitumor ...
based inBuffalo, NEW YORK (USA)
We are a medical technology company focused on changing outcomes for patients. We intend to cure all patients with implant biofilm infections by advancing technologies, enhancing the effectiveness of treatments, working alongside the existing ...
Currently under investigation to study the elimination of biofilm infections on prosthetic knee implants during early intervention procedures while maintaining the current standard of ...
based inCottesloe, AUSTRALIA
Neuroscientific Biopharmaceuticals is an Australian public company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical need. Our vision ...
EmtinB is the lead candidate that has shown to closely mimic the neuroprotective and neuroregenerative ability of MT-II. ...
based inFlorham Park, NEW JERSEY (USA)
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...
We are developing CYNK-101 as a combination treatment for multiple cancer indications. CYNK-101 is manufactured from a specific type of immune cell, NK cells, that we extract from postpartum placentas and then genetically engineer to increase cell ...
